Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.51) by 9.8 percent. This is a 2.13 percent increase over losses of $(0.47) per share from the same period last year.
HC Wainwright & Co. Initiates Coverage On Applied Digital with Buy Rating, Announces Price Target of $4
HC Wainwright & Co. analyst Kevin Dede initiates coverage on Applied Digital (NASDAQ:APLD) with a Buy rating and announces Price Target of $4.
